|
|
|
Insider
Information: |
Vitullo Nicole |
Relationship: |
10% Owner |
City: |
Richmond |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
26 |
|
Direct
Shares |
3,769,432 |
|
Indirect Shares
|
2,643,947 |
|
|
Direct
Value |
$47,143,687 |
|
|
Indirect Value
|
$8,442,934 |
|
|
Total
Shares |
6,413,379 |
|
|
Total
Value |
$55,586,620 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-29.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-12 |
8,000 |
Premium* |
|
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2005-07-28 |
668 |
2005-07-28 |
0 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-04 |
3,333 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
|
0 |
2006-05-09 |
100,355 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-28 |
5,142 |
2008-04-24 |
56,718 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
3,019 |
2011-12-22 |
50,643 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
Director |
2020-01-28 |
0 |
2020-01-28 |
0 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
Director, 10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2023-06-15 |
36,918 |
2019-03-21 |
0 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2017-12-11 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
2016-11-01 |
0 |
2013-08-27 |
32,091 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
2014-05-07 |
1,973,389 |
2014-05-01 |
0 |
Premium* |
|
Marinus Pharmaceuticals Inc |
MRNS |
Director |
2022-02-04 |
6,442 |
2021-03-16 |
0 |
Premium* |
|
Colucid Pharmaceuticals, Inc. |
CLCD |
10% Owner |
2016-09-09 |
0 |
|
0 |
Premium* |
|
Syndax Pharmaceuticals Inc |
SNDX |
10% Owner |
2016-03-08 |
1,743,854 |
2016-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
164 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NUVA |
Nuvasive Inc |
10% Owner |
|
2004-05-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,000 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
|
2005-12-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
19,166 |
|
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2006-05-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,333 |
|
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2006-05-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
100,355 |
|
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2006-10-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
27,500 |
|
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2007-05-25 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,862 |
|
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2007-05-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,862 |
|
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2007-05-25 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
2,865 |
|
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2007-11-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,963 |
|
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2007-11-27 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
3,019 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2010-08-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,032,129 |
|
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2010-11-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
11,000 |
|
- |
|
DRTX |
Durata Therapeutics, Inc. |
Director |
|
2012-07-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,250 |
|
- |
|
ESPR |
Esperion Therapeutics, In... |
Director |
|
2013-06-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
21,471 |
|
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2013-07-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,629,157 |
|
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2013-07-15 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,588,857 |
|
- |
|
TBRA |
Tobira Therapeutics Inc |
10% Owner |
|
2013-08-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
53,099 |
|
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2013-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,250 |
|
- |
|
CLCD |
Colucid Pharmaceuticals, ... |
10% Owner |
|
2015-05-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
43,669 |
|
- |
|
CLCD |
Colucid Pharmaceuticals, ... |
10% Owner |
|
2016-08-02 |
4 |
S |
$8.71 |
$279 |
D/D |
(32) |
3,168 |
0 |
- |
|
CLCD |
Colucid Pharmaceuticals, ... |
10% Owner |
|
2016-08-01 |
4 |
S |
$8.82 |
$741 |
D/D |
(84) |
3,200 |
0 |
- |
|
CLCD |
Colucid Pharmaceuticals, ... |
10% Owner |
|
2016-08-03 |
4 |
S |
$8.15 |
$1,051 |
D/D |
(129) |
3,039 |
0 |
- |
|
CLCD |
Colucid Pharmaceuticals, ... |
10% Owner |
|
2016-04-28 |
4 |
S |
$6.96 |
$1,636 |
D/D |
(235) |
3,284 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
Director |
|
2018-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
645 |
3,177 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
Director |
|
2005-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
668 |
668 |
|
- |
|
164 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|